Status:

COMPLETED

F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

Lead Sponsor:

Tammie L. S. Benzinger, MD, PhD

Conditions:

Alzheimer Disease

HIV

Eligibility:

All Genders

40+ years

Brief Summary

This project will collect quantitative pilot data that will allow the characterization of uptake and binding of 18F-AV-1451 (also known as F 18 T807, also known as T807, also known as 7-(6-fluoropyrid...

Detailed Description

This protocol will demonstrate the presence of tau fibrils in older HIV+ patients with HIV associated neurocognitive disorders (HAND) compared to cognitively normal HIV+ individuals and HIV- controls....

Eligibility Criteria

Inclusion

  • Male or female participants, ≥ 40 years of age.
  • Testing for HIV status. If positive will be included in the HIV+ group and if negative will be included in the HIV- group.
  • Females without documented history of menopause or hysterectomy will undergo a urine pregnancy test 24 hours prior to F 18 T807 drug administration.

Exclusion

  • Has any condition that, in the Investigator's opinion, could increase risk to the participant, limit the participant's ability to tolerate the experimental procedures, or interfere with the collection/analysis of the data (for example, participants with severe chronic back pain might not be able to lie still during the scanning procedures).
  • Is deemed likely unable to perform the imaging procedures for any reason.
  • Has a high risk for Torsades de Pointes or is taking medications known to prolong QT interval.
  • Has hypersensitivity to F 18 T807 or any of its excipients.
  • Contraindications to PET, PET-CT or MR (e.g. electronic medical devices, inability to lie still for long periods) that make it unsafe for the individual to participate.
  • Severe claustrophobia.
  • Currently pregnant or breast-feeding.

Key Trial Info

Start Date :

May 3 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 23 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03279523

Start Date

May 3 2016

End Date

May 23 2018

Last Update

September 22 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110